Corina Mangu
Thursday 6 June
Panel Discussion: Navigating the Complexities of Drug Safety in the Digital Age
- Discuss the role of real-world data in pharmacovigilance and its impact on drug safety assessments
- Explore opportunities for leveraging digital health data for proactive adverse event monitoring and patient-reported outcomes
- Examine ethical dilemmas related to pharmacovigilance, including issues of patient privacy, informed consent, and the balance between public health surveillance and individual rights
- Examine how AI and ML technologies are transforming pharmacovigilance processes, including adverse event detection, signal detection, and risk assessment